IGKC	IGKC enables antigen binding, part of IgG complex, involved in adaptive immune response. Located in blood microparticle, extracellular exosome. Related to HER2-positive breast cancer.
TMSB10	TMSB10 encodes thymosin beta-10, involved in actin monomer binding, regulation of cell migration, and actin monomer sequestration. It is associated with HER2-positive breast cancer, and is found in the cytoplasm and cytoskeleton.
ERBB2	ERBB2, also known as HER2, is part of the EGF receptor family of tyrosine kinases. It lacks its own ligand-binding domain, forming heterodimers with ligand-bound EGF receptors. This enhances downstream signaling pathways, such as MAPK and PI3K. ERBB2 is amplified or overexpressed in cancers, notably HER2-positive breast cancer. Variants exist due to alternative splicing and allelic variation. The common allele is Ile654/Ile655 in isoform a.
IGHG3	Enables antigen binding and immunoglobulin receptor binding. Involved in antibacterial humoral response and classical pathway complement activation. Located in blood microparticle and extracellular exosome. Associated with HER2-positive breast cancer in humans.
IGLC2	IGLC2 encodes a component of immunoglobulin lambda light chains. It is involved in immunoglobulin mediated immune response and antigen binding. Located in blood microparticles and extracellular exosomes, it may play a role in HER2-positive breast cancer through immune mechanisms.
IGHA1	IGHA1 contributes to immunoglobulin receptor binding activity, involved in glomerular filtration and regulation of respiratory burst. Located extracellularly, part of monomeric and secretory dimeric IgA complexes. Implicated in HER2-positive breast cancer, potentially influencing immune response and tumor progression.
GAPDH	Encodes glyceraldehyde-3-phosphate dehydrogenase, involved in carbohydrate metabolism and oxidative phosphorylation. Exhibits uracil DNA glycosylase activity and antimicrobial peptide function. Participates in nitrosylation, mRNA stability regulation, and acts as transferrin receptor in macrophages. Multiple pseudogenes exist. Alternative splicing leads to various transcript variants.
ACTB	ACTB encodes cytoskeletal actin, involved in cell motility, structure, and signaling. It plays a role in contractile apparatus and is expressed in nonmuscle cells. Mutations lead to Baraitser-Winter syndrome, affecting intellectual development and facial features. ACTB is linked to HER2-positive breast cancer through cellular processes like cytoskeletal rearrangement and signaling pathways. The gene has multiple pseudogenes.
IGLC3	IGLC3 encodes a lambda chain of immunoglobulin, involved in antigen binding and immune response. Found in blood microparticles and extracellular exosomes. It is part of the IgG complex, relevant in HER2-positive breast cancer as immunoglobulin activity impacts therapeutic targets.
IGHM	IGHM encodes the C region of the mu heavy chain, defining IgM isotype. IgM is an antigen recognition molecule in B cells, involved in antibody response and isotype switching. Naive B cells express IgM and IgD. Secreted IgM forms pentamers in plasma. The gene is located on chromosome 14.
SERF2	SERF2 is involved in protein destabilization, associated with HER2-positive breast cancer. It is predicted to be located in the cytosol and nucleus, influencing cancer cell behavior and progression.
PSMB3	PSMB3 encodes a 20S core beta subunit of the proteasome complex involved in peptide cleavage in a non-lysosomal pathway. It plays a role in processing class I MHC peptides and may influence trinucleotide repeat expansion linked to neurological diseases. PSMB3's involvement in HER2-positive breast cancer may relate to its proteasome function and protein degradation.
PFN1	PFN1 encodes a profilin family protein involved in actin dynamics by regulating polymerization. Associated with Miller-Dieker syndrome and Huntington disease. HER2-positive breast cancer relevance may involve actin polymerization affecting cell growth and motility. Multiple pseudogenes on chromosome 1. Actin-binding roles suggest potential influence on cancer cell behavior.
ACTG1	ACTG1 encodes cytoplasmic actin gamma 1, crucial for cell motility and cytoskeleton maintenance. Found in all cell types. Mutations linked to DFNA20/26 hearing loss and Baraitser-Winter syndrome. Alternative splicing produces multiple transcript variants.
KRT19	KRT19 encodes a keratin family protein in epithelial cells, crucial for structural integrity. It is an unpaired acidic cytokeratin in type I family, expressed in periderm. Located on chromosome 17q12-q21, associated with HER2-positive breast cancer.
RACK1	RACK1 is involved in enzyme and protein binding, regulating protein metabolism and signal transduction. It is located in the midbody, perinuclear region, and phagocytic cup, and is part of the IRE1-RACK1-PP2A complex. Relevant to HER2-positive breast cancer.
MUCL1	MUCL1 gene is associated with HER2-positive breast cancer. It is predicted to be located in Golgi lumen and plasma membrane. MUCL1 expression is noted in certain breast cancer cells, potentially playing a role in cancer progression or cell signaling pathways. MUCL1 may serve as a biomarker for cancer diagnosis or prognosis and be involved in therapeutic targeting.
CISD3	CISD3 is part of the CDGSH domain family, involved in electron transport and oxidative phosphorylation. It is associated with HER2-positive breast cancer, possibly impacting mitochondrial function and cellular metabolism.
APOE	APOE encodes a major apoprotein of chylomicrons, essential for triglyceride-rich lipoprotein catabolism. It binds to liver and peripheral cell receptors. Located on chromosome 19 with APOC1 and APOC2. Mutations cause familial dysbetalipoproteinemia, increasing plasma cholesterol and triglycerides due to impaired chylomicron and VLDL clearance. HER2-positive breast cancer links to APOE in some studies.
MIEN1	MIEN1 is implicated in HER2-positive breast cancer. It negatively regulates apoptosis and positively influences cell migration and filopodium assembly. MIEN1 is situated at the cytoplasmic side of the plasma membrane and in the cytosol.
SSR4	SSR4 gene encodes delta subunit of translocon-associated protein complex, involved in protein translocation across endoplasmic reticulum. Located in Xq28, compact with IDH3G gene, driven by CpG-embedded bidirectional promoter. Alternate splicing yields multiple transcript variants. Related to protein processing in HER2-positive breast cancer.
CALR	CALR encodes calreticulin, a chaperone protein in the endoplasmic reticulum involved in protein folding, calcium homeostasis, and cell adhesion. It also plays a role in transcription regulation. Mutations in CALR are linked to myeloproliferative neoplasms and autoimmune diseases like systemic lupus erythematosus. CALR's role in HER2-positive breast cancer is not directly established but may relate to cellular processes it regulates.
PSAP	PSAP encodes a protein involved in surfactant homeostasis and defense against pathogens. It binds carbohydrates on lipids and microorganisms. Mutations link to idiopathic pulmonary fibrosis. PSAP is studied in HER2-positive breast cancer for its potential role in tumor progression and therapeutic targeting.
CTSD	CTSD encodes an A1 family peptidase involved in protein turnover, hormone and growth factor activation. It forms cathepsin D enzyme, implicated in neuronal ceroid lipofuscinosis-10, breast cancer, and possibly Alzheimer's. Related to HER2-positive breast cancer.
FTL	FTL encodes the light subunit of ferritin, a major intracellular iron storage protein. Ferritin consists of 24 subunits, affecting iron uptake and release rates. Key functions include soluble, nontoxic iron storage. FTL defects link to neurodegenerative diseases, hyperferritinemia-cataract syndrome. Multiple pseudogenes exist. FTL's role in HER2-positive breast cancer involves iron metabolism impacting tumor growth and progression.
FTH1	FTH1 encodes the heavy subunit of ferritin, a key intracellular iron storage protein. Composed of 24 subunits of heavy and light chains, it regulates iron uptake and release. Ferritin stores iron in a soluble, nontoxic state. Defects link to neurodegenerative diseases. Multiple pseudogenes and alternatively spliced variants exist, with undetermined biological validity.
TPT1	TPT1 encodes a protein regulating cellular growth and proliferation. It involves apoptosis, protein synthesis, and cell division. The protein stabilizes microtubules and is phosphorylated for mitotic progression. TPT1 is upregulated in cancer cells and plays a role in carcinogenesis. Alternative splicing leads to multiple isoforms. HER2-positive breast cancer may involve TPT1 function alterations.
PTPRF	PTPRF is a protein tyrosine phosphatase involved in cell signaling, growth, differentiation, and oncogenic transformation. It has extracellular, transmembrane, and catalytic domains, influences epithelial cell contacts, and regulates beta-catenin signaling. Increased expression is linked to insulin resistance. Two transcript variants exist. Related to HER2-positive breast cancer.
UBA52	UBA52 encodes a fusion protein with ubiquitin and ribosomal protein L40. Ubiquitin targets proteins for degradation by the 26S proteasome, maintains chromatin structure, regulates gene expression, and responds to stress. UBA52 gene has several pseudogenes in the human genome. It is relevant in HER2-positive breast cancer due to its role in protein regulation and gene expression.
P4HB	P4HB encodes the beta subunit of prolyl 4-hydroxylase, part of protein disulfide isomerase family. Functions include hydroxylation of prolyl residues, disulfide bond rearrangement, protein aggregation inhibition, thyroid hormone binding, S-nitrosothiol-bound nitric oxide transport, and microsomal triglyceride transfer protein complex involvement.
BEST1	HER2 gene, also known as ERBB2, encodes a receptor tyrosine kinase involved in cell growth, differentiation. Overexpression or amplification of HER2 occurs in breast cancer, leading to aggressive tumor growth. Targeted therapies like trastuzumab are used. HER2 is a member of the epidermal growth factor receptor (EGFR) family, which includes EGFR, HER3, and HER4. HER2 dimerizes with other family members to activate signaling pathways influencing cell proliferation and survival in breast cancer.
HLA-B	HLA-B, part of HLA class I, encodes a membrane-anchored heavy chain forming heterodimers with beta-2 microglobulin. It presents endoplasmic peptides to the immune system, expressed in most cells. The gene has 8 exons; polymorphisms in exons 2 and 3 affect peptide binding specificity. Hundreds of alleles exist, important in transplantation typing. HER2-positive breast cancer research may involve understanding immune evasion mechanisms impacting HLA-B function.
FAU	FAU encodes a fusion protein with ubiquitin-like fubi and ribosomal protein S30. Fubi's function is unknown; S30 is part of the 40S ribosomal subunit and has antimicrobial activity. FAU is homologous to fox sequence in FBR-MuSV. Pseudogenes exist. Similar synthesis occurs with ribosomal proteins S27a, L40.
SLC9A3R1	Encodes a sodium/hydrogen exchanger regulatory cofactor. Interacts with CFTR, GPCRs, beta2-adrenergic receptor, parathyroid hormone 1 receptor. Links integral membrane and cytoskeletal proteins. Localizes to actin-rich structures. Mutations cause hypophosphatemic nephrolithiasis/osteoporosis type 2. Loss of heterozygosity implicated in HER2-positive breast cancer.
FN1	FN1 encodes fibronectin, a glycoprotein involved in cell adhesion, migration, and metastasis. It exists in plasma and extracellular matrix forms. FN1 undergoes alternative splicing, producing various transcript variants. Its functions are crucial in processes like embryogenesis, wound healing, blood coagulation, and host defense. In HER2-positive breast cancer, FN1 may interact with pathways related to tumor progression.
COL1A1	COL1A1 encodes type I collagen pro-alpha1 chains. It is found in connective tissues, bone, cornea, dermis, tendon. Mutations link to osteogenesis imperfecta, Ehlers-Danlos syndrome, Caffey Disease, idiopathic osteoporosis. Chromosome 17 and 22 translocations involving COL1A1 relate to dermatofibrosarcoma protuberans. Two transcripts exist due to alternate polyadenylation.
EEF2	EEF2 encodes a GTP-binding translation elongation factor crucial for protein synthesis. In HER2-positive breast cancer, EEF2 may influence cancer cell growth through its role in ribosomal translocation. This protein is inactivated by EF-2 kinase phosphorylation, impacting translation elongation and potentially cancer progression.
IGHG4	IGHG4 encodes a protein involved in antigen binding and immunoglobulin receptor binding. It plays a role in antibacterial humoral response and classical pathway complement activation. Located in blood microparticles and extracellular exosomes. Related to HER2-positive breast cancer.
CALML5	CALML5 encodes a calcium-binding protein related to the calmodulin family, expressed in epidermis. It binds calcium, changes conformation, and associates with transglutaminase 3 in keratinocyte differentiation. While primarily studied in skin, its role in HER2-positive breast cancer remains unclear. Further research may clarify its involvement in cancer cell signaling or differentiation.
CD74	CD74 encodes a protein that associates with MHC class II, regulates antigen presentation, and acts as a receptor for macrophage migration inhibitory factor (MIF). It initiates survival pathways, cell proliferation, and interacts with amyloid precursor protein (APP), suppressing amyloid beta production. Several transcript variants exist.
B2M	B2M gene codes for a serum protein linked with MHC class I on nucleated cell surfaces. It forms beta-pleated sheets and amyloid fibrils in some conditions. Displays antibacterial activity in amniotic fluid. Mutations cause hypercatabolic hypoproteinemia. Related to HER2-positive breast cancer.
FASN	FASN encodes an enzyme for palmitate synthesis from acetyl-CoA and malonyl-CoA with NADPH. FASN is linked to HER2-positive breast cancer, sometimes fusing with ER-alpha. It affects fatty acid metabolism and cancer cell proliferation.
S100A9	S100A9 encodes a protein in the S100 family with EF-hand calcium-binding motifs, impacting cellular processes like cell cycle and differentiation. Located on chromosome 1q21, it may inhibit casein kinase and has antimicrobial properties. Altered expression links to cystic fibrosis. In HER2-positive breast cancer, S100A9's role in tumorigenesis and immune response regulation is significant.
MGP	Encodes a vitamin K-dependent protein involved in inhibiting ectopic calcification. Secreted by chondrocytes and smooth muscle cells. Linked to vascular and synovial calcification. Mutations cause Keutel syndrome. Associated with HER2-positive breast cancer.
CFL1	CFL1 encodes cofilin, an actin-modulating protein. It polymerizes and depolymerizes F-actin and G-actin, regulated by pH and phosphorylation. It aids actin cytoskeleton reorganization and translocates actin-cofilin complex from cytoplasm to nucleus. In HER2-positive breast cancer, CFL1 may influence cell motility and invasion.
PSMD3	PSMD3 encodes a non-ATPase subunit of the 19S regulator lid in the 26S proteasome, involved in ATP/ubiquitin-dependent protein degradation. It is linked to HER2-positive breast cancer in humans. Additionally, single nucleotide polymorphisms in PSMD3 are associated with neutrophil count.
IGHG1	IGHG1 encodes a protein part of the IgG immunoglobulin complex. It enables Fc-gamma receptor I complex binding, involved in antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity, functioning in extracellular space. Related to HER2-positive breast cancer.
HLA-A	HLA-A, part of class I molecules, comprises a heavy chain and beta-2 microglobulin. Expressed in most cells, it presents ER-derived peptides for cytotoxic T cell recognition. With 8 exons, polymorphisms in exons 2 and 3 affect peptide binding. Key in immune responses against viruses, including HIV and SARS-CoV-2. Over 6000 alleles described, crucial for transplantation compatibility.
S100A6	S100A6, a S100 protein family member, has 2 EF-hand calcium-binding motifs. Located on chromosome 1q21, it regulates cell cycle, differentiation, insulin release, prolactin secretion, and exocytosis. S100A6 expression changes are linked to melanoma. HER2-positive breast cancer relevance is under investigation.
MYL6	MYL6 encodes a myosin alkali light chain expressed in smooth muscle and non-muscle tissues. Myosin is a hexameric ATPase cellular motor protein with heavy chains and light chains. MYL6 has pseudogenes and two transcript variants. Its role in HER2-positive breast cancer may involve cellular motility and structural integrity.
COL1A2	COL1A2 encodes pro-alpha2 chain of type I collagen, found in connective tissues, bone, cornea, dermis, tendon. Mutations linked to osteogenesis imperfecta, Ehlers-Danlos syndrome, idiopathic osteoporosis, atypical Marfan syndrome. Three transcripts identified. HER2-positive breast cancer relevance not directly established.
PHB	PHB is involved in cellular senescence and tumor suppression in HER2-positive breast cancer. Its 3' UTR has antiproliferative activity, functioning as a trans-acting regulatory RNA. PHB is evolutionarily conserved, with several pseudogenes and multiple transcript variants due to alternative splicing. HER2-positive breast cancer is characterized by overexpression of the HER2 protein, impacting cell growth and division.
TAGLN2	TAGLN2 encodes a protein similar to transgelin, associated with differentiated smooth muscle. It potentially acts as a tumor suppressor. TAGLN2 is implicated in HER2-positive breast cancer, with multiple transcript variants encoding different isoforms. Its role in cancer biology and gene regulation is under investigation.
HLA-E	HLA-E, part of HLA class I molecules, forms heterodimers with beta-2 microglobulin. It binds peptides from leader sequences of class I molecules. Gene has 8 exons: exon 1 for leader peptide, 2-3 for alpha domains, 4 for alpha3 domain, 5 for transmembrane, 6-7 for cytoplasmic tail. HER2-positive breast cancer relevance involves immune modulation roles in tumor environment.
HLA-C	HLA-C is part of HLA class I heavy chain paralogues, involved in immune response by presenting peptides. It consists of a heavy chain and beta-2 microglobulin, expressed in most cells. Its gene has 8 exons, with polymorphisms in exons 2 and 3 affecting peptide binding specificity. HLA-C's role includes impact on infectious diseases like malaria, HIV, and SARS-CoV-2. It is relevant for transplantation typing and immune response variations.
KRT7	KRT7 encodes a type II cytokeratin expressed in simple epithelia, lining organ cavities, gland ducts, and blood vessels. It may play a role in HER2-positive breast cancer, given its expression in epithelial tissues. The gene is located on chromosome 12q12-q13, with alternative splicing resulting in multiple transcript variants.
CD63	CD63, tetraspanin family, cell surface glycoprotein. Mediates signal transduction, affects cell development, activation, growth, motility. Complexes with integrins, associated with blood platelet activation, Hermansky-Pudlak syndrome, tumor progression. Alternative splicing produces multiple isoforms.
SYNGR2	SYNGR2 encodes a membrane protein with tyrosine-phosphorylated C-terminal tail, part of synaptogyrin family. Role in membrane traffic regulation suggested. HER2-positive breast cancer relevance is uncertain. Alternative splicing produces multiple variants.
STARD3	STARD3 encodes lipid trafficking proteins with steroidogenic acute regulatory and metastatic lymph node 64 domains, localizing to late endosome membranes. Involved in cholesterol export, STARD3 is linked to HER2-positive breast cancer. Alternative splicing produces multiple variants.
PABPC1	PABPC1 encodes a poly(A) binding protein involved in mRNA regulation. It shuttles between nucleus and cytoplasm, binds to 3' poly(A) tail, promotes ribosome recruitment, translation initiation, and poly(A) shortening for mRNA decay. Part of a gene family with three protein-coding genes and pseudogenes. Linked to HER2-positive breast cancer.
GPX4	GPX4 encodes a glutathione peroxidase involved in reducing hydrogen peroxide and lipid hydroperoxides, protecting cells from oxidative damage. It plays roles in lipid peroxidation, cell death prevention, and sperm development. GPX4 is a selenoprotein with selenocysteine, using the SECIS element for UGA codon recognition. It is linked to Sedaghatian spondylometaphyseal dysplasia. Variants undergo alternative splicing, affecting localization. In HER2-positive breast cancer, GPX4's antioxidant function may influence cancer cell survival.
GRB7	Interacts with receptor tyrosine kinases, EGFR, ephrin receptors. Involved in integrin signaling, cell migration via FAK binding. Multiple transcript variants, two isoforms identified. Linked to HER2-positive breast cancer.
SLC25A6	SLC25A6 is a mitochondrial carrier gene related to ADP/ATP translocation. It is part of the permeability transition pore complex, influencing apoptosis. Non-transcribed pseudogenes exist in the human genome. Implicated in HER2-positive breast cancer.
AEBP1	AEBP1 encodes a carboxypeptidase A family member, possibly a transcriptional repressor. It may influence adipogenesis, smooth muscle cell differentiation, wound healing, and abdominal wall development. Overexpression linked to glioblastoma. In HER2-positive breast cancer, AEBP1's role remains under investigation.
GNAS	GNAS gene exhibits complex imprinted expression with multiple transcript variants. It encodes the stimulatory G-protein alpha subunit, crucial in receptor-ligand interactions and adenylyl cyclase activation. Alternative splicing and mutations lead to various conditions, including pseudohypoparathyroidism, Albright hereditary osteodystrophy, McCune-Albright syndrome, and some pituitary tumors.
NDUFB9	NDUFB9 is a subunit of mitochondrial oxidative phosphorylation complex I, involved in electron transport. Complex I deficiency is linked to disorders like hypertrophic cardiomyopathy and neurodegenerative diseases. Pseudogenes on chromosomes 5, 7, and 8; alternative splicing creates variants. HER2-positive breast cancer is associated with altered mitochondrial function, potentially involving complex I components.
EDF1	EDF1 encodes a protein involved in endothelial cell differentiation, lipid metabolism, and hormone-induced cardiomyocyte hypertrophy. It acts as a transcriptional coactivator linking TBP with gene-specific activators. Alternate splicing results in transcript variants. EDF1's role in HER2-positive breast cancer may involve tumor progression and response to treatment. It is associated with transcription regulation and cellular signaling pathways.
CRIP2	CRIP2 encodes a transcription factor with LIM zinc-binding domains, possibly involved in smooth muscle tissue differentiation. It may interact with pathways related to HER2-positive breast cancer, influencing cell growth and survival. Alternative splicing generates multiple variants.
DDX5	DDX5, a DEAD box RNA helicase, is involved in RNA structure alteration, transcription coregulation, splicing regulation, and small noncoding RNA processing. It contains conserved motifs essential for ATP binding, hydrolysis, RNA binding, and unwinding. Dysregulation may contribute to cancer, including HER2-positive breast cancer. Alternative splicing produces multiple variants.
OAZ1	OAZ1 encodes antizyme 1, part of the ornithine decarboxylase antizyme family, regulating polyamine levels, cell growth, and proliferation. It inhibits ornithine decarboxylase, affecting polyamine biosynthesis and uptake. Expression involves +1 ribosomal frameshifting. OAZ1 has broad tissue distribution and produces distinct isoforms via alternative translation sites. It is linked to HER2-positive breast cancer through its role in cell proliferation and regulation.
EIF4G1	EIF4G1 encodes a component of the EIF4F complex, crucial for mRNA recruitment to the ribosome in protein synthesis initiation. It binds to other EIF4F members and interacts with poly(A)-binding protein, aiding mRNA circularization. Alternative splicing produces multiple variants. In HER2-positive breast cancer, EIF4G1 may influence cell growth by enhancing mRNA translation efficiency.
LMNA	LMNA gene encodes nuclear lamina proteins involved in nuclear stability, chromatin structure, and gene expression. Mutations cause diseases like Emery-Dreifuss muscular dystrophy, lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and progeria. In HER2-positive breast cancer, LMNA may influence nuclear architecture and cellular proliferation.
GNB2	GNB2 encodes a beta subunit of heterotrimeric G proteins involved in signal transduction. These proteins act as regulators of alpha subunits and certain receptors and effectors, impacting HER2-positive breast cancer pathways. The 5' UTR of GNB2 includes a CCG repeat polymorphism.
CST3	CST3 encodes a cysteine protease inhibitor from the cystatin superfamily. Located on chromosome 20, it is abundant in human fluids. CST3 mutations link to amyloid angiopathy, affecting vascular disease. It exhibits antimicrobial activity, inhibiting herpes simplex virus replication. Alternative splicing generates multiple transcript variants.
PCGF2	PCGF2 encodes a protein with a RING finger motif, similar to polycomb group gene products. It forms complexes for transcription repression in embryogenesis, cell cycles, tumorigenesis. Acts as a negative transcription regulator, with tumor suppressor activity. Expressed in tumors, limited in normal neural tissues. Knockout in mice shows regulation of cytokines, chemokines, impacting lymphocyte differentiation, migration, and immune response.
SDC1	SDC1 encodes a type I transmembrane heparan sulfate proteoglycan, part of the syndecan family. It mediates cell binding, signaling, and cytoskeletal organization, and is essential for HIV-1 tat protein internalization. SDC1 is involved in cell proliferation, migration, and cell-matrix interactions, with altered expression in various tumors, including HER2-positive breast cancer. Multiple transcript variants exist, with two major ones encoding the same protein.
S100A11	S100A11, part of the S100 protein family, contains EF-hand calcium-binding motifs. It localizes in cytoplasm/nucleus, regulating cell cycle, differentiation, motility, invasion, and tubulin polymerization. Found on chromosome 1q21, its altered expression links to tumor metastasis. Related to HER2-positive breast cancer.
PRDX1	PRDX1 is a peroxiredoxin family gene encoding antioxidant enzymes. It reduces hydrogen peroxide and alkyl hydroperoxides. Involved in cellular antioxidant protection, CD8(+) T-cell antiviral activity, and cancer progression. Four transcript variants encode the same protein, linked to HER2-positive breast cancer.
GRINA	Involved in calcium channel activity and apoptotic signaling pathways. Regulates neuron apoptosis and endoplasmic reticulum calcium ion homeostasis. Localized in Golgi membrane. Linked to HER2-positive breast cancer, potentially affecting cell signaling and survival pathways.
ATP6V0B	Encodes V0 domain of vacuolar ATPase; mediates organelle acidification. Involved in protein sorting, zymogen activation, endocytosis, synaptic vesicle proton gradient. Alternative splicing; multiple transcripts. Related to HER2-positive breast cancer.
TFF3	TFF3 is a member of the trefoil family, characterized by the trefoil motif. It is a secretory protein expressed in gastrointestinal mucosa, particularly in goblet cells of the intestines and colon. TFF3 may protect mucosa, stabilize the mucus layer, and aid epithelial healing. It is clustered with other trefoil genes on chromosome 21 and is associated with HER2-positive breast cancer in humans.
HLA-DRA	HLA-DRA encodes the alpha chain of HLA class II molecules, involved in antigen presentation to T cells. Located on antigen-presenting cells, it pairs with DRB genes, lacks polymorphisms in peptide binding, and consists of 5 exons. Relevant in HER2-positive breast cancer immune response.
EEF1D	EEF1D encodes a subunit of elongation factor-1 complex, delivering aminoacyl tRNAs to ribosomes. It acts as a guanine nucleotide exchange factor and interacts with HIV-1 Tat, repressing host protein translation and enhancing viral protein synthesis. It has alternatively spliced variants and related pseudogenes on chromosomes 1, 6, 7, 9, 11, 13, 17, 19. EEF1D's role in HER2-positive breast cancer involves protein synthesis regulation.
AZGP1	AZGP1, associated with HER2-positive breast cancer, is involved in cell adhesion and bitter taste perception. It is located in extracellular space and linked to various conditions like prostate carcinoma, gastrointestinal and lung cancers, kidney failure, liver cirrhosis, and obesity. AZGP1 acts as a biomarker for these diseases.
PPP1CA	PPP1CA encodes a catalytic subunit of protein phosphatase 1 (PP1), involved in dephosphorylation of biological targets. It regulates cellular processes including cell division, glycogen metabolism, muscle contractility, and protein synthesis. Deregulation is linked to diabetes, cancer, and cardiac issues. In HER2-positive breast cancer, PPP1CA may influence tumor progression through its role in cell proliferation and survival pathways. It has multiple isoforms due to alternative splicing.
FLNA	FLNA encodes an actin-binding protein involved in cytoskeletal remodeling, influencing cell shape and migration. It interacts with integrins, receptor complexes, and second messengers. Mutations cause syndromes like PVNH, OPD, FMD, MNS, and CIIPX. Two isoforms exist. In HER2-positive breast cancer, FLNA may affect tumor cell motility and invasiveness, potentially impacting cancer progression and treatment response.
COL3A1	COL3A1 encodes type III collagen, found in connective tissues like skin, lung, and vessels. Mutations link to Ehlers-Danlos syndrome type IV and aneurysms. Relevant to HER2-positive breast cancer.
ATP5E	ATP5E encodes the epsilon subunit of mitochondrial ATP synthase, involved in ATP synthesis during oxidative phosphorylation. Located in the F1 catalytic core, ATP5E functions with subunits alpha, beta, gamma, and delta. ATP synthase includes F1 and Fo complexes, Fo being the proton channel. Pseudogenes are found on chromosomes 4 and 13. Read-through transcripts with SLMO2 are also present.
SPDEF	SPDEF is part of the ETS transcription factor family, expressed in prostate epithelial cells, brain, breast, lung, and ovarian tumors. It acts as an androgen-independent transactivator of PSA promoter and is a potential target for cancer therapies due to better tumor association than other molecules.
AP000769.1	AP000769.1 is associated with HER2-positive breast cancer. HER2 gene, located on chromosome 17, encodes a protein receptor involved in cell growth and division. Overexpression or amplification of HER2 is linked to aggressive breast cancer. HER2-targeted therapies, like trastuzumab, are used in treatment. Monitoring HER2 status is crucial for personalized therapy decisions and prognosis in breast cancer patients.
ALDOA	ALDOA encodes a glycolytic enzyme involved in converting fructose-1,6-bisphosphate. It is linked to Glycogen Storage Disease XII and hemolytic anemia. ALDOA disruption is implicated in cancer progression, including HER2-positive breast cancer. Related pseudogenes exist on chromosomes 3 and 10.
PLXNB2	PLXNB2, a B class plexin, is a transmembrane receptor involved in axon guidance and cell migration responding to semaphorins. Research links PLXNB2 to HER2-positive breast cancer, suggesting its role in tumor progression through signaling pathways affecting cellular behavior.
TAGLN	TAGLN encodes an actin-binding protein in the calponin family, expressed in vascular and visceral smooth muscle. It marks early smooth muscle differentiation and involves calcium-independent smooth muscle contraction. TAGLN acts as a tumor suppressor, with expression loss linked to tumor development. It includes N-terminal CH and C-terminal CLIK domains. Knockout in mice alters actin filament distribution in vascular smooth muscle cells. Relevant to HER2-positive breast cancer.
TUBA1B	TUBA1B encodes a protein involved in microtubule organization, GTP binding, and GTPase activity. It participates in cytoskeleton structure and ubiquitin protein ligase binding, contributing to cellular processes in HER2-positive breast cancer.
APOC1	APOC1 encodes apolipoprotein C1, expressed in liver, involved in HDL and VLDL metabolism, inhibits cholesteryl ester transfer protein. Associated with chromosome 19, within apolipoprotein cluster. Activated in macrophage differentiation, alternative splicing yields multiple variants.
PRRC2A	PRRC2A is located in the MHC class III region, linked to TNF alpha/beta genes. It has microsatellite repeats associated with IDDM onset and may play a role in pancreatic beta-cell inflammation. It's a candidate for rheumatoid arthritis. Two transcript variants exist, encoding the same protein. Also related to HER2-positive breast cancer.
LAPTM5	LAPTM5, a transmembrane receptor linked to lysosomes, is involved in hematopoiesis. It is not directly related to HER2-positive breast cancer but may influence immune cell function, potentially affecting cancer progression.
PTMS	PTMS is linked to HER2-positive breast cancer, enables histone binding, regulates apoptosis negatively, promotes transcription via RNA polymerase II, active in nucleus.
KRT18	KRT18 encodes type I intermediate filament keratin 18, often paired with keratin 8. Expressed in single-layer epithelial tissues, mutations are linked to cryptogenic cirrhosis. Relevant to HER2-positive breast cancer due to its role in cell structure and signaling.
IFI27	IFI27 is involved in RNA polymerase II-specific DNA-binding transcription factor binding, identical protein binding, and lamin binding. It participates in defense response to symbiont, protein K48-linked ubiquitination, pyroptotic inflammatory response, and regulates transcription and protein export from nucleus. Located in mitochondrial and nuclear inner membranes, active in mitochondrion. Potential relevance to HER2-positive breast cancer through these cellular processes.
PLD3	PLD3 encodes a phospholipase D enzyme involved in membrane phospholipid hydrolysis. The protein is a type II membrane protein with two phosphodiesterase domains, affecting amyloid-beta precursor processing. Mutations are linked to Alzheimerâ€™s disease risk. Alternate splicing results in transcript variants. Relation to HER2-positive breast cancer needs further investigation.
ADAM15	ADAM15, part of ADAM family, involves in cell adhesion, proteolytic ectodomain processing. Contains zinc-binding metalloprotease, disintegrin-like, EGF-like domains. Interacts with integrin beta 3, Src family kinases, impacting cellular signaling, adhesion. Linked to HER2-positive breast cancer. Multiple transcript variants exist.
C1QA	C1QA encodes the A-chain of C1q, part of the complement system, linking with C1r and C1s. Deficiency can lead to lupus erythematosus and glomerulonephritis. C1q includes 18 polypeptide chains: 6 A-chains, B-chains, and C-chains, with collagen-like and globular domains. Alternate splicing generates transcript variants. HER2-positive breast cancer association is unclear but may involve immune response pathways.
AES	AES gene encodes a protein part of the groucho/TLE family, related to embryonic neurogenesis. It can form homo- or heterooligomers to repress gene expression within its family. AES is implicated in HER2-positive breast cancer pathways. Three transcript variants exist.
TSPO	TSPO, located in mitochondria, interacts with benzodiazepines and regulates cholesterol transport for steroid hormone synthesis. It's relevant in HER2-positive breast cancer, influencing cellular signaling and survival. Variants exist; some are non-coding. TSPO may impact cancer treatment response and prognosis.
MLLT6	MLLT6 is associated with histone and nucleosome binding, influencing transcription regulation by RNA polymerase II. It may play roles in renal processes like potassium, sodium excretion, and water absorption. Key activity occurs in the nucleus. In HER2-positive breast cancer, MLLT6 may impact gene expression regulation, contributing to cancer progression.
TAPBP	TAPBP encodes a transmembrane glycoprotein that mediates the interaction between MHC class I molecules and TAP, essential for antigenic peptide transport and loading. It is located on chromosome 6 within the major histocompatibility complex. Alternative splicing produces three isoforms. In HER2-positive breast cancer, TAPBP's role in immune response regulation may influence tumor immune evasion.
SCAND1	SCAND1 encodes a protein with a SCAN domain involved in transcription regulation. It interacts with myeloid zinc finger 1B. SCAND1 lacks a zinc finger motif, differentiating it from other SCAN-related genes. HER2-positive breast cancer connection involves transcription factor activity modification, impacting gene expression pathways.
ATP1A1	ATP1A1 encodes the alpha 1 subunit of Na+/K+ -ATPase, a P-type cation transport ATPase crucial in maintaining Na and K electrochemical gradients across the plasma membrane. These gradients are vital for osmoregulation, sodium-coupled transport, and electrical excitability in nerve and muscle cells. In HER2-positive breast cancer, ATP1A1 may influence tumor cell proliferation and survival through ion homeostasis. Multiple transcript variants exist, encoding various isoforms.
CD81	CD81 encodes a tetraspanin family protein involved in cell signal transduction, development, activation, growth, and motility. It complexes with integrins, promoting muscle cell fusion and myotube maintenance. CD81 is localized in a tumor-suppressor region, being a malignancy candidate gene. Two transcript variants exist.
SEC61A1	SEC61A1 is part of the SECY/SEC61-alpha family, involved in polypeptide insertion into the endoplasmic reticulum. It encodes an alpha subunit of the SEC61 complex, associated with ribosomes, and interacts with SEC61 beta and gamma subunits. SEC61A1 may influence HER2-positive breast cancer by affecting protein processing pathways.
CLDN3	CLDN3 encodes a protein in the claudin family, integral to tight junctions in epithelial cells, serving as a barrier. It acts as a receptor for Clostridium perfringens enterotoxin and shares sequence similarity with a rat apoptosis-related protein. CLDN3 is associated with HER2-positive breast cancer, influencing cell adhesion and permeability.
PPDPF	Involved in cell differentiation; influences TORC1 signaling, liver development; located in mitochondrion; associated with HER2-positive breast cancer.
S100A14	S100A14, part of S100 protein family, binds calcium with EF-hand motif. Located on chromosome 1. Lower protein levels in HER2-positive breast cancer tissue suggest tumor suppressor role, potentially linked to metastasis.
BGN	BGN encodes a small leucine-rich proteoglycan involved in bone growth, muscle development, collagen fibril assembly, inflammation, and innate immunity. It may influence atherosclerosis and aortic valve stenosis. Related to decorin gene via duplication. HER2-positive breast cancer involvement needs further study.
C3	C3 is a complement system gene crucial for classical and alternative pathways. It produces C3a anaphylatoxin, impacting inflammation and antimicrobial functions. Mutations connect to hemolytic uremic syndrome and macular degeneration. C3's role in HER2-positive breast cancer involves immune modulation and tumor progression.
MZT2B	MZT2B is involved in HER2-positive breast cancer. It is located in the cytosol, microtubule cytoskeleton, and nucleoplasm, and is part of the gamma-tubulin ring complex, crucial for microtubule nucleation.
S100A8	S100A8 encodes an S100 family protein with EF-hand calcium-binding motifs. Localized in cytoplasm/nucleus, it regulates cellular processes like cell cycle and differentiation. Located on chromosome 1q21, it may inhibit casein kinase and act as a cytokine. Altered expression links to cystic fibrosis. Multiple isoforms exist. Relevant to HER2-positive breast cancer.
MDK	MDK encodes a secreted growth factor binding heparin, responding to retinoic acid. It promotes cell growth, migration, angiogenesis, tumorigenesis. Targeted for therapeutic applications. Has alternatively spliced transcript variants.
PFDN5	PFDN5 encodes a prefoldin alpha subunit involved in polypeptide stabilization and correct folding. Prefoldin is a chaperone complex with two alpha and four beta subunits. PFDN5 may repress c-Myc transcriptional activity. Alternative splicing produces different isoforms. Implicated in HER2-positive breast cancer through chaperone-mediated folding mechanisms.
H2AFJ	H2AFJ encodes a replication-independent histone variant in the H2A family, located on chromosome 12. It structures nucleosomes in chromatin and possesses a divergent C-terminus. Additionally, it encodes an antimicrobial peptide with antibacterial and antifungal activity. H2AFJ is implicated in HER2-positive breast cancer by influencing chromatin dynamics and gene expression.
SH3BGRL3	SH3BGRL3 is involved in cytoskeleton organization, localizes to cytosol, nuclear body, and ruffle membrane, with implications in HER2-positive breast cancer.
ENO1	ENO1 encodes alpha-enolase, a glycolytic enzyme and structural lens protein. It forms homodimers with alpha, beta, or gamma subunits. Alternative splicing produces a shorter isoform that binds the c-myc promoter, acting as a tumor suppressor. Pseudogenes are located on chromosome 1. Alpha-enolase is linked to Hashimoto encephalopathy and plays a role in HER2-positive breast cancer.
XBP1	XBP1 encodes a transcription factor involved in MHC class II gene regulation, binds to X box promoter, and enhances T cell leukemia virus expression. It undergoes IRE1-mediated splicing during ER stress, producing active XBP1(S) and regulatory XBP1(U). Functions in viral protein expression and ER stress response. Pseudogene located on chromosome 5.
CYBA	CYBA encodes the alpha subunit of cytochrome b. It is part of the oxidase system in phagocytes. Mutations lead to chronic granulomatous disease, affecting superoxide generation. CYBA's role in HER2-positive breast cancer is not directly established.
COX6B1	COX6B1 encodes a nuclear subunit of cytochrome c oxidase (COX), involved in electron transfer in the mitochondrial respiratory chain. This gene, linked to infantile encephalomyopathy, has three pseudogenes on chromosomes 7, 17, and 22q13.1-13.2. COX6B1's role in HER2-positive breast cancer remains unclear but may involve mitochondrial function regulation and assembly.
TRAF4	TRAF4, a TNF receptor-associated factor, mediates signal transduction in the TNF receptor superfamily. It interacts with neurotrophin receptor p75, regulating cell death and NF-kappa B activation. TRAF4 binds p47phox, linking it to oxidative activation of MAPK8/JNK. It's associated with HER2-positive breast cancer, with various transcript variants.
CD24	CD24 is a sialoglycoprotein linked to the cell surface via glycosyl phosphatidylinositol. It modulates growth and differentiation of mature granulocytes and B cells. CD24 gene is located on chromosome 6, with non-transcribed pseudogenes on chromosomes 1, 15, 20, and Y. Known for alternative splicing, CD24 is implicated in HER2-positive breast cancer.
PRSS8	PRSS8, a serine protease in the chymotrypsin family, generates a heterodimeric enzyme through proteolytic processing. Expressed in prostate epithelia, it's found in seminal fluid. PRSS8 cleaves substrates at lysine or arginine residues, mediates epithelial sodium channel activation, and influences epithelial barrier formation. Relevant to HER2-positive breast cancer, it may affect tumor microenvironment by modulating protease activity and cellular interactions.
MMP14	MMP14 encodes a membrane-type matrix metalloproteinase involved in extracellular matrix breakdown and activates MMP2. It plays a role in physiological processes like tissue remodeling and disease processes including metastasis, relevant to HER2-positive breast cancer. MMP14 remains at the cell surface, influencing tumor invasion.
MUC1	MUC1 encodes a mucin family protein crucial for forming mucous barriers and intracellular signaling. Expressed on epithelial surfaces, it cleaves into alpha and beta subunits for adhesion and signaling. Overexpression and glycosylation changes link to carcinomas. Contains polymorphic VNTR domain; alternative splicing yields transcript variants.
VIM	VIM encodes type III intermediate filament protein, integral to cytoskeleton structure. It maintains cell shape, cytoplasm integrity, and stabilizes cytoskeletal interactions. VIM is involved in neuritogenesis, cholesterol transport, cell attachment, migration, and signaling. Pathogens attach to VIM on host cell surface. Mutations linked to congenital cataracts. VIM's role in HER2-positive breast cancer relates to tumor cell migration and invasion.
MIDN	MIDN gene enables molecular adaptor activity, involved in ubiquitin-independent protein catabolism. Located in cytoplasm and nucleus. Associated with HER2-positive breast cancer in humans.
SPINT2	SPINT2 encodes a transmembrane protein with extracellular Kunitz domains inhibiting serine proteases. It inhibits HGF activator, preventing active hepatocyte growth factor formation. SPINT2 functions as a tumor suppressor; mutations cause congenital sodium diarrhea. Multiple transcript variants exist. Related to HER2-positive breast cancer, SPINT2 may influence tumor progression through protease regulation.
BST2	BST2 is a gene encoding a protein involved in B-cell growth and development. It is implicated in HER2-positive breast cancer and rheumatoid arthritis.
TIMP1	TIMP1 encodes a protein inhibiting matrix metalloproteinases, involved in extracellular matrix degradation, cell proliferation, and anti-apoptosis. It is inducible by cytokines and hormones and shows polymorphic X chromosome inactivation in females. Associated with HER2-positive breast cancer.
GUK1	GUK1 encodes an enzyme that catalyzes phosphorylation of GMP to GDP using ATP. It is a potential target for cancer chemotherapy, with multiple transcript variants encoding isoforms. In HER2-positive breast cancer, altered GUK1 activity may contribute to tumor progression and therapeutic resistance.
ACTN4	Alpha actinin ACTN4 belongs to the spectrin gene superfamily, acts as actin-binding protein involved in cytoskeletal organization, cell adhesion, and metastatic processes. Mutations associated with focal and segmental glomerulosclerosis. In HER2-positive breast cancer, ACTN4 may influence tumor progression and metastasis by altering cell motility and adhesion.
CTSB	CTSB encodes a lysosomal cysteine protease involved in protein turnover and amyloid precursor protein processing. Overexpression is linked to esophageal adenocarcinoma and other tumors. CTSB and Cathepsin L cleave SARS-CoV-2 spike protein. CTSB has pseudogenes and transcript variants.
COX4I1	Cytochrome c oxidase (COX) is the terminal enzyme of the mitochondrial respiratory chain, facilitating electron transfer and proton gradient formation. COX4I1 encodes a nuclear subunit IV isoform 1, involved in regulation and assembly. Located near NOC4 gene, shares promoter. Pseudogenes exist on chromosomes 13, 14. Alternative splicing produces transcript variants. HER2-positive breast cancer relevance due to mitochondrial function impact.
CCT3	CCT3 encodes a chaperone in the CCT complex, aiding ATP-dependent protein folding. Involved in folding actin, tubulin. Has alternate splice variants, pseudogene on chromosome 8. Linked to HER2-positive breast cancer.
HNRNPA2B1	HNRNPA2B1 is part of the hnRNPs A/B subfamily, influencing pre-mRNA processing, mRNA metabolism, and transport. It binds hnRNA, shuttles between nucleus and cytoplasm, and has two quasi-RRM domains. It produces two alternatively spliced transcript variants encoding distinct isoforms. Associated with HER2-positive breast cancer.
SEPW1	SEPW1 encodes a selenoprotein with a selenocysteine residue, using UGA codon for Sec incorporation. The 3' UTR contains SECIS element for Sec recognition. Expressed in muscle, heart, brain, it has a thioredoxin-like fold and CxxU motif, suggesting redox activity. In mice, it aids muscle growth, differentiation, and neuronal oxidative stress protection. A pseudogene is on chromosome 1.
LY6E	LY6E encodes a GPI-anchored protein involved in T cell function, oncogenesis, and immune regulation. It modulates viral infections like SARS-CoV, MERS-CoV, and SARS-CoV-2. LY6E is associated with HER2-positive breast cancer.
SCD	Enzyme in fatty acid biosynthesis, synthesizes oleic acid. Part of fatty acid desaturase family, integral membrane protein in endoplasmic reticulum. Transcripts: ~3.9, 5.2 kb, differing by polyadenylation signals. Similar gene on chromosome 4, pseudogene on chromosome 17. Linked to HER2-positive breast cancer.
HSPB1	HSPB1 encodes a small heat shock protein involved in protein folding. It translocates to the nucleus under stress. Linked with poor outcomes in cancers, it aids proliferation and metastasis, protecting cells from apoptosis. Mutations associate with Charcot-Marie-Tooth disease and neuropathy. Relevant in HER2-positive breast cancer.
EIF4G2	EIF4G2 encodes a protein similar to eIF4G, involved in translation initiation via eIF4F complex. Unlike eIF4G, EIF4G2 represses translation by forming inactive complexes. It initiates translation at non-AUG (GUG) codon. EIF4G2 is relevant in HER2-positive breast cancer due to its role in regulating protein synthesis, affecting cancer cell proliferation and survival.
BSG	Basigin (BSG) is a plasma membrane protein involved in spermatogenesis, embryo implantation, neural network formation, and tumor progression. It is part of the immunoglobulin superfamily and expressed in various tissues. Linked to HER2-positive breast cancer, BSG may play a role in cancer cell proliferation and metastasis. Multiple transcript variants exist for this gene.
ZYX	ZYX encodes zyxin, a zinc-binding phosphoprotein at focal adhesions in actin cytoskeleton. It has an N-terminal proline-rich domain, interacting with SH3 domains, and three C-terminal LIM domains for protein binding. Zyxin modulates cytoskeletal organization and adhesion-induced gene expression changes, with multiple transcript variants encoding the same isoform. In HER2-positive breast cancer, ZYX may affect cell adhesion and signaling pathways.
TUBB	Encodes beta tubulin, forming dimers with alpha tubulin for microtubule structure. In HER2-positive breast cancer, microtubule dynamics are essential for cell division. Mutations lead to cortical dysplasia. Alternative splicing produces variants. Pseudogenes on chromosomes 1, 6, 7, 8, 9, and 13.
LASP1	LASP1 encodes a LIM protein, part of the nebulin family, involved in cAMP and cGMP signaling. It binds to actin cytoskeleton at cell membrane extensions. LASP1 is associated with metastatic breast cancer, hematopoietic tumors, B-cell lymphomas, and colorectal cancer.
CD99	CD99 protein aids leukocyte migration, T-cell adhesion, and transmembrane transport. Involved in T-cell death via caspase-independent pathway. Rearranges actin cytoskeleton, possibly acts as oncosuppressor in osteosarcoma. Located in pseudoautosomal region of X and Y chromosomes. Escapes X-chromosome inactivation; adjacent pseudogene present.
COL6A2	COL6A2 encodes an alpha chain of type VI collagen, found in connective tissues. It contains von Willebrand Factor type A domains, binding extracellular matrix proteins, organizing matrix components. Mutations link to Bethlem myopathy, Ullrich muscular dystrophy. Three transcript variants exist. Related to HER2-positive breast cancer.
H1FX	H1FX encodes a replication-independent histone, part of the H1 family, involved in nucleosome structure. Histones are nuclear proteins forming chromatin by interacting with DNA. The gene relates to HER2-positive breast cancer, affecting chromatin structure and gene expression.
RALY	RALY encodes a member of the hnRNP family, involved in pre-mRNA splicing and embryonic development. It has multiple transcript variants. RALY may interact with HER2-related pathways in breast cancer.
UBE2M	UBE2M encodes an E2 ubiquitin-conjugating enzyme. It is involved in protein ubiquitination, a process for protein degradation, and is linked with NEDD8 for conjugation to proteins like Cdc53/culin. UBE2M has implications in HER2-positive breast cancer through its role in cellular protein regulation and degradation pathways.
SPARC	SPARC encodes a cysteine-rich protein involved in extracellular matrix synthesis and calcification of bone collagen. It influences cell shape and is linked to tumor suppression and metastasis, affecting tumor cell invasion. There are three transcript variants encoding different isoforms.
ATG10	ATG10 is an E2-like enzyme in autophagy, facilitating ATG12-ATG5 conjugation and MAP-LC3 modification for autophagosome formation, linked to HER2-positive breast cancer in humans.
HSP90AB1	HSP90AB1 encodes the constitutive cytosolic 90 kDa heat-shock protein involved in signal transduction, protein folding, degradation, and morphological evolution. It plays a role in gastric apoptosis and inflammation. Alternative splicing results in multiple transcript variants. Pseudogenes exist on multiple chromosomes. HSP90AB1 is associated with HER2-positive breast cancer.
ORMDL3	ORMDL3 is involved in ceramide metabolism, negatively regulates B cell apoptosis and ceramide biosynthesis, and promotes protein localization to the nucleus. It is located in the endoplasmic reticulum and is part of the serine palmitoyltransferase complex. Related to HER2-positive breast cancer.
LMAN2	LMAN2 encodes a type I transmembrane lectin involved in protein trafficking between the endoplasmic reticulum, Golgi apparatus, and plasma membrane. It binds high mannose type glycoproteins, facilitating sorting and quality control. LMAN2 may play a role in HER2-positive breast cancer cell signaling and proliferation, impacting therapeutic strategies.
CHCHD2	CHCHD2 encodes a CX(9)C protein that translocates from mitochondria to nucleus under stress, binding to a 13-nucleotide oxygen responsive element in cytochrome oxidase 4I2 promoter. It regulates mitochondria-mediated apoptosis by decreasing in response to apoptotic stimuli, facilitating BCL2-associated X protein oligomerization and caspase activation. Pseudogenes exist on multiple chromosomes, and alternative splicing creates transcript variants.
COX7C	COX7C encodes a subunit of cytochrome c oxidase, part of the mitochondrial respiratory chain. It participates in electron transfer and complex assembly. COX7C shares high sequence identity with mouse and bovine COX VIIc and is present in all tissues. A pseudogene, COX7CP1, is located on chromosome 13. COX7C is associated with HER2-positive breast cancer in humans.
ARHGDIA	ARHGDIA encodes a protein regulating Rho GTPase signaling, maintaining them inactive by inhibiting GDP disassociation. It affects cellular processes and its expression may alter in tumors, including HER2-positive breast cancer. Mutations associate with nephrotic syndrome type 8. Alternate splicing yields multiple variants.
VMP1	VMP1 encodes a transmembrane protein involved in autophagy regulation. Overexpression triggers autophagy in nutrient-rich conditions. It is overexpressed in pancreatitis, aiding zymophagy in acinar cells. VMP1's role is linked to HER2-positive breast cancer.
UBC	UBC gene encodes ubiquitin C, a polyubiquitin precursor. Ubiquitination affects protein degradation, DNA repair, cell cycle, kinase modification, endocytosis, and signaling. In HER2-positive breast cancer, altered ubiquitination affects tumor progression and treatment response.
IGFBP2	IGFBP2 encodes a protein binding IGF-I and IGF-II, influencing tumor growth. It exists in secreted and nonsecreted isoforms. High expression is linked to HER2-positive breast cancer prognosis.
COPE	COPE encodes an epsilon subunit of the coatomer protein complex involved in Golgi-to-ER transport. Essential for vesicle budding from Golgi membranes, it binds dilysine motifs. Variants encode different isoforms. HER2-positive breast cancer links to altered Golgi transport, potentially involving the COPE gene's coatomer function.
NUPR1	NUPR1 is involved in DNA binding and transcription coactivator activities. It regulates cell cycle, oxidative phosphorylation, and catabolic processes, and negatively regulates programmed cell death. NUPR1 is located in the nucleoplasm, intercellular bridge, and perinuclear cytoplasm, and is part of the protein-DNA complex. It plays a role in HER2-positive breast cancer by influencing cellular processes.
PERP	Involved in activating cysteine-type endopeptidase activity, regulating neutrophil chemotaxis, and linked to desmosomes and plasma membranes. Active in cell-cell junctions, associated with erythrokeratodermia variabilis, and mutilating palmoplantar keratoderma with periorificial keratotic plaques. Related to HER2-positive breast cancer.
KRT81	KRT81, a type II hair keratin gene, forms hair/nails with type I keratins. Located on chromosome 12q13, it belongs to a subfamily including KRTHB1, KRTHB3, KRTHB6. Expressed in hair cortex. Mutations linked to monilethrix. Some assemblies show non-coding due to SNP. Not directly linked to HER2-positive breast cancer.
PPP1R1B	PPP1R1B encodes a signal transduction molecule linked to HER2-positive breast cancer. It regulates phosphorylation through dopaminergic and glutamatergic receptor pathways, acting as a kinase or phosphatase inhibitor. This gene's role in neurological disorders suggests a potential therapeutic target. Multiple isoforms exist.
LGALS3BP	LGALS3BP, located on chromosome 17q25, encodes a protein involved in cell-cell and cell-matrix interactions. It is elevated in cancer and HIV patients and is linked to immune responses, specifically NK and LAK cell cytotoxicity. The protein binds to Mac-2 and galectin 1.
SSR2	SSR2 encodes the beta subunit of the signal sequence receptor, involved in protein translocation across the endoplasmic reticulum membrane. It maps to chromosome 1q21-q23. SSR2 is linked to HER2-positive breast cancer, facilitating aberrant protein processing relevant to cancer progression.
KIAA0100	KIAA0100 is linked to HER2-positive breast and prostate cancer, regulated by miR-195. It shows high expression in cancerous cells, influencing invasiveness. Alternative splicing results in variants with RNA pol II promoter FMP27 and Golgi-body-localization APT1 domains. In mice, it's an antigen on acute monocytic leukemia cells.
MYL9	MYL9 encodes a myosin light chain involved in muscle contraction, regulating ATPase activity of myosin heads. It binds calcium and is activated by myosin light chain kinase. Two transcript variants exist. In HER2-positive breast cancer, MYL9 may influence tumor cell motility and invasion.
CIB1	CIB1 is part of the EF-hand calcium-binding superfamily. It interacts with proteins like integrin alpha-IIb-beta-3, DNA-PK, presenilin-2, FAK, PAK, and PKD. It may influence cell survival, proliferation, and is linked to cancer, including HER2-positive breast cancer, and Alzheimer's disease. Alternative splicing creates multiple transcripts.
IDH2	IDH2 encodes mitochondrial NADP(+)-dependent isocitrate dehydrogenase, catalyzing isocitrate to 2-oxoglutarate. It interacts with pyruvate dehydrogenase complex, impacting metabolism and energy. In HER2-positive breast cancer, IDH2 may influence tumor metabolism and growth. Alternative splicing yields multiple variants.
STARD10	STARD10 is associated with lipid binding and transport, involved in bile acid secretion and peroxisome proliferator-activated receptor signaling. It is located in the cytosol and linked to HER2-positive breast cancer.
LGALS1	LGALS1 is a beta-galactoside-binding protein involved in cell-cell and cell-matrix interactions. It may function as an autocrine negative growth factor regulating cell proliferation. It is relevant in HER2-positive breast cancer due to its role in cellular interactions and growth regulation.
COX6C	COX6C encodes subunit VIc of cytochrome c oxidase, a mitochondrial respiratory chain enzyme. It facilitates electron transfer from cytochrome c to oxygen. Nuclear-encoded, COX6C has 77% amino acid identity with mouse VIc. It is up-regulated in prostate cancer. A pseudogene is located on chromosome 16p12. Related to HER2-positive breast cancer.
GRN	GRN encodes progranulin, a precursor to granulins, involved in cell growth regulation. Granulins are secreted peptides derived from progranulin, impacting tumorigenesis, development, and wound healing. HER2-positive breast cancer may involve granulin-mediated pathways affecting cell proliferation and growth regulation.
MAPKAPK2	MAPKAPK2 encodes a Ser/Thr protein kinase regulated by p38 MAP kinase, involved in stress responses, inflammation, nuclear export, gene expression, and cell proliferation. It phosphorylates HSP27 and has two isoforms. In HER2-positive breast cancer, MAPKAPK2 may play a role in tumor progression through these pathways.
GNAI2	GNAI2 encodes a G protein alpha subunit involved in adenylate cyclase regulation and signal transduction. It plays a role in HER2-positive breast cancer cell signaling. Multiple isoforms exist.
KDELR1	KDELR1 encodes a receptor facilitating ER protein retrieval via KDEL signal in animal cells. It is part of the KDEL receptor family, structurally/functionally similar to yeast ERD2. HER2-positive breast cancer involves KDELR1 in intracellular protein sorting, impacting cellular signaling and growth regulation.
COL18A1	COL18A1 encodes type XVIII collagen, involved in extracellular matrix. Produces endostatin, inhibiting angiogenesis and tumor growth. Linked to Knobloch syndrome affecting retinal structure. Alternative splicing creates multiple variants. Related to HER2-positive breast cancer.
UQCRQ	UQCRQ encodes a protein in the mitochondrial respiratory chain's complex III, involved in electron transport. It's linked to HER2-positive breast cancer through its role in cellular metabolism and energy production.
COX5B	COX5B encodes a nuclear-encoded subunit Vb of cytochrome c oxidase, the terminal enzyme in the mitochondrial respiratory chain. It facilitates electron transfer and proton gradient formation across the inner mitochondrial membrane. COX5B's role in HER2-positive breast cancer is not clearly defined, but mitochondrial function alteration can influence cancer cell metabolism and growth.
ELOVL1	ELOVL1 gene encodes enzyme for fatty acid elongation, crucial in biosynthesis processes including sphingolipids. Present in endoplasmic reticulum, potentially influencing HER2-positive breast cancer through lipid metabolism. ELOVL1's activity may affect cell membrane properties, impacting cancer cell signaling and growth.
CHPF	CHPF gene encodes an enzyme involved in chondroitin sulfate biosynthesis. It facilitates N-acetylgalactosaminyl and glucuronosyl transferase activities, contributing to polysaccharide chain formation. Located in Golgi membrane, active in Golgi apparatus. Role in HER2-positive breast cancer remains under investigation.
CLDN4	CLDN4 encodes a claudin family protein integral to epithelial cell tight junctions, regulating solute and ion movement. It's a high-affinity receptor for Clostridium perfringens enterotoxin and involved in organ development. Deleted in Williams-Beuren syndrome, impacting multiple systems. Related to HER2-positive breast cancer.
C12orf57	C12orf57 is ubiquitously expressed and vital for corpus callosum development. Mutations link to Temtamy syndrome. Variants exist. HER2-positive breast cancer involves altered signaling pathways, where genes like C12orf57 may play roles in cell proliferation and differentiation.
LGALS3	Encodes galectin family protein binding beta-galactosides. N-terminal proline-rich domain, C-terminal carbohydrate recognition domain. Localizes extracellular matrix, cytoplasm, nucleus. Involved apoptosis, immunity, cell adhesion, T-cell regulation. Antimicrobial activity. Alternate splicing yields variants.
HSP90AA1	HSP90AA1 encodes an inducible molecular chaperone involved in protein folding, functioning as a homodimer with ATPase activity. It interacts with co-chaperones and has two transcript variants encoding different isoforms. HSP90AA1 is linked to HER2-positive breast cancer by stabilizing the HER2 protein, influencing cancer progression.
JUP	JUP encodes a cytoplasmic protein in submembranous plaques, interacting with cadherins. It's part of the catenin family with armadillo repeat motifs. Mutations link to Naxos disease. It's involved in cell adhesion and signaling, relevant to HER2-positive breast cancer. Alternative splicing noted.
A2M	A2M encodes a protease inhibitor and cytokine transporter using bait-and-trap mechanism. It inhibits proteases like trypsin and thrombin, and inflammatory cytokines, affecting inflammatory cascades. Mutations cause alpha-2-macroglobulin deficiency. In Alzheimer's, it aids in clearing A-beta. Located on chromosome 12p. HER2-positive breast cancer relevance involves potential modulation of tumor-related proteases and cytokines.
NDUFB7	NDUFB7 encodes a subunit of mitochondrial complex I, involved in electron transfer from NADH to ubiquinone in the respiratory chain. Associated with HER2-positive breast cancer.
PGAP3	PGAP3 encodes a GPI-specific phospholipase localized in the Golgi apparatus, involved in remodeling GPI-anchored proteins, affecting protein sorting and trafficking. Mutations cause neurologic hyperphosphatasia with cognitive disability (HPMRS4). Related to HER2-positive breast cancer, it plays a role in cell signaling pathways. Alternative splicing leads to multiple isoforms.
HSPA8	HSPA8 encodes a heat shock cognate protein involved in protein folding and transport. It acts as a chaperone and ATPase, aiding polypeptide folding and vesicle disassembly. Variants exist due to alternative splicing. Its role in HER2-positive breast cancer is linked to cellular stress response and protein homeostasis.
TCEB2	TCEB2 encodes elongin B, part of the transcription factor B (SIII) complex with elongins A/A2, B, and C. It regulates RNA polymerase II elongation by reducing pausing. Elongin B and C interact with the von Hippel-Lindau tumor suppressor, inhibiting elongation. Two splice variants exist; pseudogenes are on chromosomes 11 and 13.
PEBP1	PEBP1 encodes a phosphatidylethanolamine-binding protein involved in MAPK, NF-kappa B, and GSK-3 pathways. It's linked to cancer, possibly as a metastasis suppressor. Processes into HCNP, related to neural development. PEBP1 is studied in HER2-positive breast cancer. Multiple pseudogenes exist.
COPS9	COPS9 is involved in cellular response to UV, cytoplasmic sequestering of protein, and negative regulation of protein neddylation. It is located in chromatin, cytoplasm, and nucleus. Expression may affect HER2-positive breast cancer pathways.
ATP5G2	ATP5G2 encodes a subunit of mitochondrial ATP synthase involved in ATP synthesis during oxidative phosphorylation. ATP synthase consists of F1 (catalytic core) and Fo (proton channel). ATP5G2 is one of three genes encoding subunit c of Fo. It is linked to HER2-positive breast cancer. This gene has multiple pseudogenes.
ATP6AP1	ATP6AP1 encodes a component of the vacuolar ATPase (V-ATPase) involved in acidification of intracellular organelles. V-ATPase has a cytosolic V1 domain and a transmembrane V0 domain. Its acidification function supports processes like protein sorting, zymogen activation, receptor-mediated endocytosis, and may aid neuroendocrine granule acidification. The gene might also influence early development. In HER2-positive breast cancer, organelle acidification is crucial for tumor progression.
MYH9	MYH9 encodes non-muscle myosin IIA, involved in cytokinesis, cell motility, and cell shape. Linked to sensorineural deafness, Epstein, Alport, Sebastian, and Fechtner syndromes. Associated with HER2-positive breast cancer.
LSM4	LSM4 encodes an RNA-binding protein involved in U6 snRNA interaction, critical for pre-mRNA splicing and U4/U6 snRNP formation. Multiple isoforms result from alternative splicing. While not directly linked to HER2-positive breast cancer, understanding RNA-binding proteins can provide insights into cancer mechanisms, potentially affecting therapeutic strategies targeting RNA splicing in HER2-positive breast cancer.
COX8A	COX8A encodes a nuclear subunit of cytochrome c oxidase, part of the electron transport chain in mitochondria. It modulates catalytic function and contributes to proton gradient formation. In HER2-positive breast cancer, mitochondrial activity can affect tumor growth and response to therapy.
UQCR11	UQCR11 encodes a component of ubiquinol-cytochrome c reductase in the mitochondrial respiratory chain, possibly binding the iron-sulfur protein. Associated with HER2-positive breast cancer, it plays a role in cellular energy production and may influence cancer cell metabolism.
ATP5B	ATP5B encodes the beta subunit of mitochondrial ATP synthase. It plays a role in ATP synthesis via proton gradient across the inner membrane in oxidative phosphorylation. ATP synthase has two complexes: F1 (catalytic core) and Fo (proton channel). F1 includes subunits alpha, beta, gamma, delta, epsilon, while Fo comprises subunits a, b, c. ATP5B is linked to energy metabolism in HER2-positive breast cancer.
DHCR24	DHCR24 encodes an FAD-dependent oxidoreductase for cholesterol biosynthesis, targeting the endoplasmic reticulum. Mutations linked to desmosterolosis. Reduced expression in Alzheimerâ€™s temporal cortex and overexpression in adrenal gland cancer. Related to HER2-positive breast cancer.
PTBP1	PTBP1 encodes a protein part of hnRNPs, binds hnRNA, influences mRNA processing, transport. It binds intronic polypyrimidine tracts, aids U2 snRNP binding to pre-mRNAs, functions in ubiquitin-proteasome pathway, localized in nucleoplasm, perinucleolar structure. Alternative splicing yields different isoforms. Implicated in HER2-positive breast cancer, may affect cancer cell RNA metabolism, splice variants.
EIF3B	EIF3B is a component of the eukaryotic translation initiation factor 3 complex. It enables RNA binding and contributes to translation initiation factor activity. Involved in IRES-dependent viral translational initiation, translational initiation, and viral translational termination-reinitiation. Located in cytoplasmic stress granules. Associated with HER2-positive breast cancer in humans.
NDUFA3	NDUFA3 encodes a subunit of mitochondrial respiratory chain complex I, involved in assembly and electron transport. Located in mitochondrion's inner membrane. While not directly linked, NDUFA3's function is vital for cellular energy and may affect cancer cell metabolism, indirectly influencing HER2-positive breast cancer progression.
FKBP2	FKBP2 encodes a protein in the immunophilin family, involved in immunoregulation, protein folding, and trafficking. It acts as a cis-trans prolyl isomerase binding FK506 and rapamycin, likely functioning as an ER chaperone and membrane scaffold component. Variants encoding the same protein exist, relevant in HER2-positive breast cancer.
MMACHC	MMACHC gene encodes a protein potentially involved in cobalamin binding and trafficking. Mutations are linked to methylmalonic aciduria, homocystinuria type cblC. HER2-positive breast cancer is driven by ERBB2, not directly related to MMACHC.
RABAC1	RABAC1 is involved in HER2-positive breast cancer, enabling identical protein binding activity. It is located in the membrane and interacts with HER2 signaling pathways. RABAC1 may play a role in cellular proliferation and survival in cancer cells, potentially affecting treatment outcomes. Targeting this gene could influence therapeutic strategies for HER2-positive breast cancer.
ISG15	ISG15 encodes a ubiquitin-like protein involved in interferon-induced immune response. It targets intracellular proteins, influences cell signaling, exhibits chemotactic activity, and has antiviral roles. ISG15 conjugates are linked to intermediate filaments and occasionally secreted. Related to HER2-positive breast cancer, ISG15 may impact cancer progression and immune evasion.
PTMA	PTMA gene encodes prothymosin alpha, involved in transcription regulation and histone binding. It plays a role in negative regulation of apoptosis. PTMA is expressed in the cytosol and nucleoplasm. In HER2-positive breast cancer, PTMA may influence tumor progression by modulating gene expression related to cell proliferation and survival.
RRBP1	RRBP1 encodes a ribosome-binding protein on the ER membrane, involved in ER proliferation, secretory pathways, and ER-microtubule interactions. It undergoes alternative splicing, resulting in protein isoforms with varying ribosome-binding affinity. Pseudogenes exist on chromosomes 3 and 7, and it is not linked to Alagille syndrome. RRBP1 is associated with HER2-positive breast cancer.
POSTN	POSTN encodes a secreted extracellular matrix protein involved in tissue development and regeneration, supporting epithelial cell adhesion and migration. It influences cancer stem cell maintenance and metastasis, relevant to HER2-positive breast cancer. Alternative splicing leads to multiple isoforms.
C1QB	C1QB encodes the B-chain of C1q, part of complement system. C1q, comprising 18 polypeptides, binds C1r and C1s. Deficiency links to lupus and glomerulonephritis. HER2-positive breast cancer may involve complement pathways, impacting immune response or tumor progression.
BCAP31	BCAP31 encodes a transmembrane protein in the endoplasmic reticulum, involved in transport to the Golgi and apoptosis. It links to CADDS syndrome. Alternative splicing produces variants; two pseudogenes are on chromosome 16. In HER2-positive breast cancer, BCAP31 may influence tumor progression and treatment response.
PSMB4	PSMB4 encodes a 20S core beta subunit of the proteasome complex, involved in ATP/ubiquitin-dependent peptide cleavage. It contributes to the processing of class I MHC peptides via the immunoproteasome, which is implicated in HER2-positive breast cancer pathogenesis.
LAPTM4A	LAPTM4A encodes a protein with four transmembrane domains, potentially involved in transporting small molecules across endosomal and lysosomal membranes. Its role in HER2-positive breast cancer remains under study, with implications for cellular transport mechanisms and tumor progression.
INTS1	INTS1 is part of the Integrator complex, linking with RNA polymerase II for 3' end processing of snRNAs U1 and U2. It may play a role in HER2-positive breast cancer through gene expression regulation and cellular processes influencing cancer progression.
FNBP1L	FNBP1L encodes a protein binding to CDC42 and N-WASP, facilitating actin polymerization via the N-WASP-WIP complex, linking cell signals to the cytoskeleton. It may play a role in HER2-positive breast cancer. Alternative splicing results in various isoforms.
JTB	JTB gene is involved in HER2-positive breast cancer. It enables protein kinase binding, participates in mitotic cytokinesis, and regulates protein kinase activity. It is located in the cytoplasm, microtubule cytoskeleton, and midbody.
NBL1	NBL1 is a member of CAN family, containing CTCK-like domain. It acts as BMP antagonist, binding BMPs and preventing receptor interaction, impacting growth and development. Alternative splicing and read-through transcripts with MINOS1 gene noted. HER2-positive breast cancer relevance involves signaling pathways influenced by BMP antagonism.
HM13	HM13 encodes a protein in the endoplasmic reticulum involved in intramembrane proteolysis of signal peptides. This process generates HLA-E epitopes recognized by the immune system and processes hepatitis C virus core protein. HM13 is an integral membrane protein with presenilin-type aspartic protease motifs. Multiple transcript variants and isoforms exist.
SLC2A4RG	SLC2A4RG encodes a nuclear transcription factor activating SLC2A4 gene. It interacts with myocyte enhancer factor 2. In HER2-positive breast cancer, gene expression regulation may influence glucose transport processes.
ROMO1	ROMO1, a mitochondrial membrane protein, increases reactive oxygen species (ROS) levels. It exhibits antimicrobial activity by disrupting bacterial membranes. Its association with HER2-positive breast cancer suggests a role in tumor progression and response to treatments targeting ROS regulation.
SERINC2	SERINC2 is linked to HER2-positive breast cancer, predicted to enable acetyltransferase activator activity, involved in phosphatidylserine metabolism and located in extracellular exosome.
NDUFA11	NDUFA11 encodes a subunit of mitochondrial complex I, part of the electron transport chain. Complex I dysfunction linked to mitochondrial diseases. In HER2-positive breast cancer, energy metabolism alterations may involve NDUFA11. Mutations can impair NADH-ubiquinol reductase activity, affecting cellular respiration. Alternate splicing yields transcript variants.
RHOC	RHOC encodes a Rho family GTPase involved in actin cytoskeleton reorganization, influencing cell shape, attachment, motility. Localizes to cytoplasm, plasma membrane, prenylated C-terminus. Overexpressed in HER2-positive breast cancer, linked to tumor proliferation, metastasis. Multiple spliced variants encode same protein.
TXNIP	TXNIP encodes a thioredoxin-binding protein involved in cellular redox signaling, oxidative stress, cellular metabolism, and ER stress. It inhibits thioredoxin, leading to reactive oxygen species accumulation. TXNIP may also act as a tumor suppressor in HER2-positive breast cancer. Multiple transcript variants exist.
TYMP	TYMP encodes thymidine phosphorylase, an angiogenic factor targeting endothelial cells, promoting angiogenesis. Mutations link to mitochondrial neurogastrointestinal encephalomyopathy. Relevant to HER2-positive breast cancer, influencing tumor growth and vascular supply. Alternative splicing generates multiple transcript variants.
NACA	NACA gene encodes a protein forming nascent polypeptide-associated complex (NAC) with BTF3, blocking SRP interaction, preventing ER mistranslocation. It's an IgE autoantigen in atopic dermatitis. Alternative splicing yields multiple variants. Pseudogenes exist on various chromosomes. Linked to HER2-positive breast cancer.
HSP90B1	HSP90B1 encodes an ATP-metabolizing chaperone that stabilizes and folds proteins, localized to melanosomes and the endoplasmic reticulum. It's linked to pathogenic states, including tumors like HER2-positive breast cancer. MicroRNA is within the 5' exon; pseudogenes are on chromosomes 1 and 15.
SNRPB	SNRPB encodes a nuclear protein part of snRNPs involved in pre-mRNA splicing. It may affect snRNP structure. Autoantibodies in lupus often target this protein. Two isoforms, B and B', exist. SNRPB is related to HER2-positive breast cancer in humans.
PFKL	PFKL encodes liver subunit of phosphofructokinase enzyme, catalyzing D-fructose 6-phosphate to D-fructose 1,6-bisphosphate in glycolysis. In HER2-positive breast cancer, altered glycolysis may affect tumor metabolism. Enzyme forms tetramers with subunits from different genes. Alternative splicing produces multiple transcript variants.
VCP	VCP encodes an AAA ATPase family protein involved in protein degradation, membrane fusion, DNA repair, cell cycle, NF-kappa B activation. It forms a homohexamer and interacts with cofactors. Mutations cause IBMPFD, ALS, Charcot-Marie-Tooth disease. Related to HER2-positive breast cancer.
ERGIC1	ERGIC1 encodes a membrane protein involved in ER-Golgi transport, interacts with protein family members to regulate turnover. HER2-positive breast cancer may affect ERGIC1's role in cellular transport, impacting cancer progression.
NUCKS1	NUCKS1 encodes a nuclear protein conserved in vertebrates, featuring phosphorylation sites for casein kinase II and cyclin-dependent kinases, nuclear localization signals, and a DNA-binding domain. Phosphorylation by Cdk1 occurs during mitosis. Associated with HER2-positive breast cancer, influencing cell cycle progression and tumorigenesis.
PSMD8	PSMD8 encodes a non-ATPase subunit of the 19S regulator in the 26S proteasome. Proteasomes are key for peptide cleavage in eukaryotic cells via an ATP/ubiquitin-dependent process. They play roles in MHC class I peptide processing. PSMD8 is involved in protein degradation pathways related to HER2-positive breast cancer, affecting cell cycle progression and apoptosis. A pseudogene is located on chromosome 1.
CALM2	CALM2 is part of the calmodulin gene family, encoding a calcium-binding protein involved in signaling, cell cycle, and proliferation. Mutations linked to long-QT syndrome (LQTS) and ventricular tachycardia. Pseudogenes on chromosomes 10, 13, 17. Alternative splicing produces various isoforms.
AP2S1	AP2S1 encodes the small chain of the AP-2 clathrin-associated adaptor complex, involved in endocytosis at the plasma membrane. It affects HER2-positive breast cancer by influencing receptor internalization. AP2S1 alternative splicing leads to multiple transcript variants, impacting cellular processes related to cancer progression.
DBI	DBI gene encodes a protein interacting with benzodiazepines, located in mitochondria of peripheral tissues. Involved in cholesterol transport for steroid synthesis. Transcript variants exist; one is non-coding, others encode the same protein.
C4orf48	C4orf48 is associated with mRNA 3'-UTR binding, 3'-UTR-mediated mRNA stabilization, and spermatogenesis. It is located in the perinuclear region of the cytoplasm and active in the extracellular space. Its role in HER2-positive breast cancer remains unexplored.
SDF4	SDF4 encodes a stromal cell-derived factor in the CREC family with six EF-hand motifs. It binds calcium, localizes to the Golgi lumen, and may regulate calcium-dependent cellular activities. In HER2-positive breast cancer, SDF4's role is not well-defined but may influence cancer cell behavior through calcium regulation.
TPI1	TPI1 encodes an enzyme that catalyzes isomerization of G3P and DHAP in glycolysis/gluconeogenesis. Mutations cause triosephosphate isomerase deficiency. Pseudogenes on chromosomes 1, 4, 6, 7. Alternative splicing produces multiple transcripts. Related to HER2-positive breast cancer.
